Finally, immunohistochemical staining of PAI-1 in samples from ESCC patients who receive cisplatin after surgery demonstrates a correlation between high PAI-1 expression in CAFs and a worse progression-free survival after chemotherapy [88]. This evidence concerns the gene SERPINE1 and esophageal squamous cell carcinoma.